TITLE:
NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes

CONDITION:
Diabetes

INTERVENTION:
insulin aspart

SUMMARY:

      This trial is conducted in the United States of America (USA). The aim of this trial is to
      assess control of blood sugar, safety, and patient acceptance of insulin aspart compared to
      insulin lispro, both in insulin pumps, in standard clinical practice.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  People with Type I or Type II Diabetes

          -  18 Years or Older.
      
